This has some parallels with therapies targeting TNF, which are effective in rheumatoid arthritis but not in multiple sclerosis, and indeed can worsen multiple sclerosis or provoke de novo central nervous system demyelination40,41. The gene discussed is TNF; the disease is multiple sclerosis.